Recruiting Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015) NCT04924075 Conditions Abnormalities, Multiple, Adenoma, Adenoma, Islet Cell, +31 more Locations Cedars-Sinai Medical Center ( Site 0110) — Los Angeles, California, United States Northwestern University - Robert H. Lurie Comprehensive Cancer Center ( Site 0130) — Chicago, Illinois, United States Northwestern Medicine Cancer Center - Warrenville ( Site 0134) — Warrenville, Illinois, United States University of Iowa ( Site 0104) — Iowa City, Iowa, United States View all 84 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States NCT06321055 Conditions Advanced Gastrointestinal Stromal Tumor Locations Bayer — Whippany, New Jersey, United States View Trial Details
Completed Evaluate the Efficacy of AMG 706 to Treat Advanced Gastrointestinal Stromal Tumors NCT00254267 Conditions Advanced Gastrointestinal Stromal Tumor, Digestive System Diseases, Digestive System Neoplasms, +7 more Locations Not specified View Trial Details
